| |
original article |
Date |
Title |
Authors Max. 6 Authors |
| 1 |
[GO] |
2024―May―04 |
Transfected SARS-CoV-2 spike DNA for mammalian cell expression inhibits p53 activation of p21(WAF1), TRAIL Death Receptor DR5 and MDM2 proteins in cancer cells and increases cancer cell viability after chemotherapy exposure |
Shengliang Zhang, Wafik S. El-Deiry |
| 2 |
[GO] |
2023―Sep―25 |
Addendum: Impact of Covid-19 on the management of patients with metastatic melanoma |
Michèle Welti, Phil F. Cheng, Joanna Mangana, Mitchell P. Levesque, Reinhard Dummer, Laurence Imhof |
| 3 |
[GO] |
2023―Sep―22 |
Reassessing the risks and benefits of COVID-19 precautions in 2023 |
Thomas A. Ollila, Rashida Taher, Prashanth Moku |
| 4 |
[GO] |
2022―Dec―29 |
Impact of Covid-19 on the management of patients with metastatic melanoma |
Michèle Welti, Phil F. Cheng, Joanna Mangana, Mitchell P. Levesque, Reinhard Dummer, Laurence Imhof |
| 5 |
[GO] |
2021―Sep―30 |
Cell fusion as a link between the SARS-CoV-2 spike protein, COVID-19 complications, and vaccine side effects |
Yuri Lazebnik |
| 6 |
[GO] |
2020―Nov―24 |
Treatment of elderly patients with refractory/relapsed multiple myeloma: oral drugs adherence and the COVID-19 outbreak |
Flávia Dias Xavier, Fernando Sergio Blumm Ferreira, Rodrigo Martins Abreu |
| 7 |
[GO] |
2020―Nov―17 |
MEK inhibitors reduce cellular expression of ACE2, pERK, pRb while stimulating NK-mediated cytotoxicity and attenuating inflammatory cytokines relevant to SARS-CoV-2 infection |
Lanlan Zhou, Kelsey Huntington, Shengliang Zhang, Lindsey Carlsen, Eui-Young So, Cassandra Parker, Ilyas Sahin, Howard Safran, Suchitra Kamle, Chang-Min Lee, Chun Geun Lee, Jack A. Elias, Kerry S. Campbell, Mandar T. Naik, Walter J. Atwood, Emile Youssef, Jonathan A. Pachter, Arunasalam Navaraj, Attila A. Seyhan, Olin Liang, Wafik S. El-Deiry |
|
